Literature DB >> 7694286

Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells.

R A Henderson1, A L Cox, K Sakaguchi, E Appella, J Shabanowitz, D F Hunt, V H Engelhard.   

Abstract

An endogenous peptide recognized by a murine T-cell clone specific for the human class I major histocompatibility complex-encoded molecule HLA-A2.1 was identified through the use of microcapillary high-performance liquid chromatography coupled with electrospray-ionization tandem mass spectrometry. The peptide was associated with HLA-A2.1 on both normal cells and the antigen-processing-mutant cell line T2. This observation demonstrates that a processing mechanism other than that involving the transporter associated with antigen processing (TAP) proteins 1 and 2 can produce peptides that can be recognized by T cells. The peptide was also recognized by four other independently derived murine HLA-A2.1-specific murine T-cell clones. This suggests that xenogeneic responses are directed at a restricted subset of major histocompatibility complex product-associated peptides. Finally, quantitation of this peptide in cell extracts using mass spectrometry showed it to be among the most dominant HLA-A2.1 associated species on human lymphoid cells. The potential relevance of this observation to models of alloreactivity will be discussed. The methodology described should be generally useful for the identification of peptide epitopes recognized by alloreactive, tumor-specific, and autoimmune T cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694286      PMCID: PMC47757          DOI: 10.1073/pnas.90.21.10275

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Molecular analysis of the association of HLA-B53 and resistance to severe malaria.

Authors:  A V Hill; J Elvin; A C Willis; M Aidoo; C E Allsopp; F M Gotch; X M Gao; M Takiguchi; B M Greenwood; A R Townsend
Journal:  Nature       Date:  1992-12-03       Impact factor: 49.962

2.  Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry.

Authors:  D F Hunt; R A Henderson; J Shabanowitz; K Sakaguchi; H Michel; N Sevilir; A L Cox; E Appella; V H Engelhard
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

3.  Alloreactive T cells discriminate among a diverse set of endogenous peptides.

Authors:  W R Heath; K P Kane; M F Mescher; L A Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

4.  Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens?

Authors:  P Matzinger; M J Bevan
Journal:  Cell Immunol       Date:  1977-03-01       Impact factor: 4.868

5.  Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling.

Authors:  E L Huczko; W M Bodnar; D Benjamin; K Sakaguchi; N Z Zhu; J Shabanowitz; R A Henderson; E Appella; D F Hunt; V H Engelhard
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

6.  Isolation and characterization of monoclonal mouse cytotoxic T lymphocytes with specificity for HLA-A,B or -DR alloantigens.

Authors:  V H Engelhard; C Benjamin
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

7.  Specificity of mouse cytotoxic T lymphocytes stimulated with either HLA-A and -B or HLA-DR antigens reconstituted into phospholipid vesicles.

Authors:  V H Engelhard; J F Kaufman; J L Strominger; S J Burakoff
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

8.  Precise prediction of a Kk-restricted cytotoxic T cell epitope in the NS1 protein of influenza virus using an MHC allele-specific motif.

Authors:  J Cossins; K G Gould; M Smith; P Driscoll; G G Brownlee
Journal:  Virology       Date:  1993-03       Impact factor: 3.616

9.  Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes.

Authors:  E G Pamer; J T Harty; M J Bevan
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

10.  On the nature of peptides involved in T cell alloreactivity.

Authors:  O Rötzschke; K Falk; S Faath; H G Rammensee
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  23 in total

1.  An exponential dilution gradient system for nanoscale liquid chromatography in combination with MALDI or nano-ESI mass spectrometry for proteolytic digests.

Authors:  C E Doneanu; D A Griffin; E L Barofsky; D F Barofsky
Journal:  J Am Soc Mass Spectrom       Date:  2001-11       Impact factor: 3.109

2.  Generation of CD8+ T cells specific for transporter associated with antigen processing deficient cells.

Authors:  E Z Wolpert; M Petersson; B J Chambers; J K Sandberg; R Kiessling; H G Ljunggren; K Kärre
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Single MHC mutation eliminates enthalpy associated with T cell receptor binding.

Authors:  Peter J Miller; Yael Pazy; Brian Conti; David Riddle; Ettore Appella; Edward J Collins
Journal:  J Mol Biol       Date:  2007-07-26       Impact factor: 5.469

4.  The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.

Authors:  Victor H Engelhard
Journal:  Int J Mass Spectrom       Date:  2007-01-01       Impact factor: 1.986

Review 5.  Direct identification of tumor-associated peptide antigens.

Authors:  V H Engelhard
Journal:  Springer Semin Immunopathol       Date:  1996

6.  The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.

Authors:  Juan Antonio Vizcaíno; Peter Kubiniok; Kevin A Kovalchik; Qing Ma; Jérôme D Duquette; Ian Mongrain; Eric W Deutsch; Bjoern Peters; Alessandro Sette; Isabelle Sirois; Etienne Caron
Journal:  Mol Cell Proteomics       Date:  2019-11-19       Impact factor: 5.911

Review 7.  Peptide binding to MHC class I molecules: implications for antigenic peptide prediction.

Authors:  K C Parker; M Shields; M DiBrino; A Brooks; J E Coligan
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

Review 8.  Vaccine therapy for cancer.

Authors:  D C Linehan; P S Goedegebuure; T J Eberlein
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

9.  Epitope mapping of HSV-1 glycoprotein K (gK) reveals a T cell epitope located within the signal domain of gK.

Authors:  Yanira Osorio; Kevin R Mott; Abdul M Jabbar; Alberto Moreno; Timothy P Foster; Konstantin G Kousoulas; Homayon Ghiasi
Journal:  Virus Res       Date:  2007-05-11       Impact factor: 3.303

10.  The peptide p2Ca is immunodominant in allorecognition of Ld by beta chain variable region V beta 8+ but not V beta 8- strains.

Authors:  J M Connolly
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.